rocmans (15 Ergebnisse)

Broché. Zustand: Bon. 64 p., 7 fig. n/b, 11 pl. coul. Inv. 25565.

Hardcover. Zustand: Wie neu. X, 280 S. ; Ill.; 27,5 cm, Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 1120.

1999. 19 x 27 cm. X, 280 S. X, 280 p. 3 illus. in color. hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, dah (Medical Radiology; Radiation Oncology). Sprache: Englisch.

Collection "Wallonie, art et histoire" n°41, 72 pages + illustrations (C.560).

Zustand: New. pp. x + 280 56 Figures.

Oorspronkelijk uitgevers omslag, softcover, 127 pages, Text NL/FR, .nieuwstaat/bon etat!! Architectuurtekeningen uit de historische steden van België = Dessins architecturaux des villes historiques de belgique 0 g.

Hardcover: 19.3 x 0 x 27 cm. 1999. 290 p. Unread book. Like new! 9783540625483 Sprache: Englisch Gewicht in Gramm: 939.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Taschenbuch. Zustand: Neu. Progress and Perspective in the Treatment of Lung Cancer | Paul Van Houtte (u. a.) | Taschenbuch | Medical Radiology | x | Englisch | 2011 | Springer | EAN 9783642641404 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Progress and Perspective in the Treatment of Lung Cancer | Paul Van Houtte (u. a.) | Taschenbuch | Medical Radiology | x | Englisch | 1999 | Springer | EAN 9783540625483 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Lung cancer is not a single disease process but is a group of biologically variable diseases. Therefore, accurate and complete diagnosis along with complete workup of the patient prior to decision-making in treatment is essential to devise the most appropriate treatment strategy. In North America adenocarcinoma of the lung now accounts for about 40% of all lung cancers and stage for stage these tumors have a poorer prognosis than squamous cell cancers of the lung. Many prognostic indicators have been identified such as genetic markers and neuroen docrine differentiation, which have important roles to play in identifying the patients who would benefit most from active treatment. Screening and early detection have been thought to be sine qua non in early diagnosis of lung cancer. However, a number of controlled trials assessing the value of annual screening for lung cancer have demonstrated in some studies that chest X-rays and/or cytology screening may improve stage distribution, resectability, survival, and fatality but has not shown an impact on disease-specific mortality rates. The Mayo Clinic lung project compar ing quarterly chest X-rays and sputum cytology with routine care in more than 10 000 male smokers indicated that 5-year survival following treatment in the screened patients was better than rates in contemporary clinical practice. However, arguments have been ad vanced as to factors that might have biased the clinical benefits. Other trials are currently under way to deal with this issue along with new molecular markers that may enhance sputum sensitivity.

Paperback. Zustand: Brand New. reprint edition. 290 pages. 10.63x0.70x7.60 inches. In Stock.

Couverture rigide. Zustand: bon. R320052724: 1999. In-Folio. Relié. Bon état, Couv. convenable, Dos satisfaisant, Intérieur frais. 190 pages augmentées de nombreuses photos en couleurs e en noir et blanc in et hors texte - Jaquette en bon, état. Avec Jaquette. . . Classification Dewey : 949.3-Belgique.

Zustand: Good. Envoi rapide Bon état bonne tenue légères rousseurs sur la couverture. in8. 1984. Agrafé. 56 pages. Good.